Cloud Complications | GenomeWeb

Cloud Complications

Premium

That cloud computing has yet to become widely regarded as a no-brainer for genomics researchers has not stopped the onslaught of marketing hype aimed at convincing researchers that the cloud is the salve to soothe all of their computational woes. Commercial and open-source academic efforts demonstrate that the most realistic strategy for converting genomics researchers to the cloud is by offering solutions where those users do not have to think about using the cloud at all, or at the very least, recreating or retaining as many of the comforts of home as possible.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.